Both in Pharmaceuticals
Kardigan vs Rapport Therapeutics
Over the past year KARD returned −27.3% and RAPP returned −47.6%; their daily moves had a correlation of 0.56.
KARD −27.3% RAPP −47.6%Growth of $1, one year, split-adjusted
| Metric | KARD | RAPP |
|---|---|---|
| Price | $13.47 | $22.86 |
| Market cap | $1.26B | $1.10B |
| Today | −0.96% | −16.99% |
| 1 month | −8.1% | −30.8% |
| 6 months | — | −30.7% |
| Year to date | — | −24.7% |
| 1 year | — | −13.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 54.8× |
| Net cash | $597.6M | $436.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 78.6% |
| Short % of float | 13.8% | 10.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).